CL
AVXL icon

Choreo LLC’s Anavex Life Sciences AVXL Stock Holding History

Choreo LLC’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.7K Sell
31,499
-492
-2% -$2.13K ﹤0.01% 1541
2025
Q4 		$122K Sell
31,991
-957
-3% -$5.86K ﹤0.01% 1499
2025
Q3 		$293K Sell
32,948
-463
-1% -$4.7K ﹤0.01% 1242
2025
Q2 		$308K Buy
33,411
+10,789
+48% +$92.1K ﹤0.01% 1156
2025
Q1 		$194K Buy
+22,622
New +$214K ﹤0.01% 1319

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Choreo LLC's AVXL Position: Q1 2026 in Review

Choreo LLC reduced its Anavex Life Sciences (AVXL) stake by 1.5% in Q1 2026, selling an estimated $2.13K and leaving 31,499 shares worth $96.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Choreo LLC first reported a position in AVXL in Q1 2025 and has held it in 5 quarters since. The position peaked at $308K in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Choreo LLC held 31,499 shares of Anavex Life Sciences worth $96.7K as of Q1 2026.
  • Choreo LLC sold 492 Anavex Life Sciences shares in Q1 2026, an estimated $2.13K.
  • Anavex Life Sciences made up ﹤0.01% of Choreo LLC's portfolio in Q1 2026, its #1541 holding.
  • Choreo LLC first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • Choreo LLC's Anavex Life Sciences position peaked at $308K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.